Mom | Outdoor Enthusiast | Hepato-centric | Alcohol-Associated Liver Disease | Assistant Professor | Account reflects my views, not my employers
Maryland, USA
Joined September 2019
- Tweets5K
- Following1.7K
- Followers2.5K
- Likes24.1K
Pinned Tweet
📢Anyone caring for patients with alcohol-associated liver disease!
This one-pager summarizes the @AASLDtweets guideline on ALD.
It is a must-have for all residents, hospitalists, and GI Fellows! @LiverFellow @geneyim #MedEd
🧭 Guidelines Corner
🍷 Alcohol-Associated Liver Disease affects millions each year, but what do the newest #AASLD guidelines actually recommend?
@ElinaStoffel breaks it down in a crisp, high-yield summary ✨
🔖Read it here ➡️ aasld.org/liver-fellow-netwo…
DOI: 10.1002/hep.30866
Hanna Blaney, MD, MPH retweeted
HepMadness!!!! Pick the most important topic in hepatology
The tournament is back. Fill out your brackets here tourneytopia.com/aasld/hepma…
Hanna Blaney, MD, MPH retweeted
Dear physician,
Did you know that at least 25% of us struggle with imposter syndrome?
It is not surprising that we have higher rates of imposter syndrome than the general population.
As perfectionists, we have a broad definition of failure but a narrow definition of success.
Our achievements never feel enough.
Hanna Blaney, MD, MPH retweeted
Great case for Medical 🏠 for AUD w/ liver disease.
84% “⬆️ calorie & ⬇️ nutrition”
“🙋🏻♀️ don’t understand that their bodies cannot handle 1-2 🍷 a day”
Social determinants, support are 🔑.
New models are needed and @BlaneyMD is leading the way @AmCollegeGastro !
Hanna Blaney, MD, MPH retweeted
🍷 + liver disease- great discussion on the fear and need for 💊 by @BlaneyMD at @AmCollegeGastro .
She encourages us to OWN, know and RX these outcome changing therapies!
Multi-Disciplinary care, non judgmental mini- interventions, community resources are life saving!
Hanna Blaney, MD, MPH retweeted
Dr Hanna Blaney @BlaneyMD outlining medical homes for patients with alcoholic liver disease at the postgrad course #ACG2026 medications for alcohol use disorder result in improved survival @AmCollegeGastro multidisciplinary care is important
Hanna Blaney, MD, MPH retweeted
Time to rethink alcohol associated liver disease with a medical home model!
Thanks Dr @BlaneyMD – at Nashville, TN
Hanna Blaney, MD, MPH retweeted
Great talk by Dr. @BlaneyMD at #ACG2026 on Medical Homes and Alcohol-Associated Liver Disease (ALD)!
Key takeaways:
• ALD and AUD often coexist
• Screen for AUD using AUDIT-C
• Treat AUD alongside liver disease
• Abstinence improves prognosis
@AmCollegeGastro @VCU_Liver
Please read the full text here through November 28th!
@Denisse_RubioC @juanpabloarab @LuisAntonioDiaz @VCU_Liver
authors.elsevier.com/a/1nvik…
Excited to share our analysis of a large international SLD database confirming suboptimal performance of FIB4/other biomarkers for detecting fibrosis in women, especially those < age of 35. With SLD increasing, we need better NITS!
@Denisse_RubioC @LuisAntonioDiaz @juanpabloarab
Join me at #ACG2026!
📅 SUnday, Oct 11 at the 8 am session
I will be discussing Medical Homes for ALD for the @AmCollegeGastro Post-Graduate Course!
See you there!
Every gastroenterologist and hepatologist needs to get comfortable with screening, diagnosing, and prescribing AUD pharmacotherapy.
📢You cannot treat ALD without treating the underlying cause, which is alcohol use!
Hanna Blaney, MD, MPH retweeted
Hepatology’s simplest equation:
1. 🍺 Alcohol-associated liver disease is the main killer.
2. 📈 Abstinence improves survival.
Yet addiction training is missing from the curriculum.
Addiction medicine must be core training. Lives depend on it.
Hanna Blaney, MD, MPH retweeted
Our LFN leads are bringing their research to #ACG2026! 🎉
We’re excited to highlight their presentations and the great work they’ve been doing.
If you’re attending ACG, be sure to stop by, check out their research, and connect with them!
See you in Nashville! 👇
Hanna Blaney, MD, MPH retweeted
Excited to share that our review article on the FIB-4 Index in SLD.
Grateful to my co-authors and mentors.
doi.org/10.1111/apt.71037
@juanpabloarab @BlaneyMD @LuisAntonioDiaz @vinayjaha
@RichSterlingMD @ASRG_Liver @OmarAdnanA
#Hepatology #Gastroenterology #SLD #FIB4
Hanna Blaney, MD, MPH retweeted
At the #ACG2026 Postgraduate Course, Dr. @ebtapper will discuss the brand new ACG Clinical Guideline on Preventive Care for Patients with Cirrhosis! Will you be there?
📕Read the guideline: bit.ly/acg-preventive-cirrho…
🗣️Register for the PG Course: bit.ly/acg-2026-register
Sadly (still) relevant thoughts from a much younger me (written while in Asia but applicable to today’s US):
Reflections on a rape in Cambodia (titled: Blaming the Victim):
hannablaney.wordpress.com/20…
And reflections on rape in India (the conversation still very relevant in the US):
hannablaney.wordpress.com/20…
Hanna Blaney, MD, MPH retweeted
In our @AGA_CGH study of 2,870 people screened for MASH trials, 11% had PEth ≥20 ng/mL—warranting evaluation for possible MetALD or ALD. Better alcohol assessment could improve trial selection and interpretation.
authors.elsevier.com/c/1ntqg…
#MASH #MetALD #ALD
As this has generated a lot of "discussion," I will say this:
Many of the best physicians in American (leaders in patient care, research, MedEd, & organized medicine) are IMG.
When did we stop wanting the world's best + brightest to serve our population & make us healthier?
I've been busy putting together presentations for ALD and the majority of studies that I am citing are from @HepCommJournal
@ebtapper has done a wonderful job shaping this field by attracting and publishing these important studies 👏🙏